Evidence map›Paper›PMID 33978932›Full record

ArticleAnnals of nuclear medicine2021

Manual on the proper use of sodium astatide ([

Tadashi Watabe, Makoto Hosono, Seigo Kinuya, Takahiro Yamada, Sachiko Yanagida, Masao Namba, Yoshihide Nakamura

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of nuclear medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. First-in-Human Study of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Manual on the proper use of theAnnals of nuclear medicine · 2024
    Article
  8. Production of [EJNMMI radiopharmacy and chemistry · 2024
    Article
  9. Targeted α-therapy using astatine (European journal of nuclear medicine and molecular imaging · 2023
    Article
  10. Article
  11. Comparison of the Therapeutic Effects of [International journal of molecular sciences · 2022
    Article
  12. Manual on the proper use of meta-[Annals of nuclear medicine · 2022
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tadashi WatabeDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan. watabe@tracer.med.osaka-u.ac.jp.ORCID http://orcid.org/0000-0001-8658-2395
Makoto HosonoDepartment of Radiology, Faculty of Medicine, Kindai University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Seigo KinuyaJapanese Society of Nuclear Medicine, 3-1-17 Nishi-Azabu, Minato-ku, Tokyo, 106-0031, Japan.
Takahiro YamadaAtomic Energy Research Institute, Kindai University, Higashi-Osaka, 3-4-1 Kowakae, Osaka, 577-8502, Japan.
Sachiko YanagidaJapan Radioisotope Association, 2-28-45 Honkomagome, Bunkyo-ku, Tokyo, 113-0021, Japan.
Masao NambaJapan Radioisotope Association, 2-28-45 Honkomagome, Bunkyo-ku, Tokyo, 113-0021, Japan.
Yoshihide NakamuraChiyoda Technol Corporation, 1-7-12 Yushima, Bunkyo-ku, Tokyo, 113-8681, Japan.

Funding

Ministry of Health, Labour and Welfare 19IA1004
6 · The paper itself

Abstract

We present the guideline for use of [

Indexed as

Alpha ParticlesClinical Trials as TopicHumansInjectionsJapanPeptidesRadiation ProtectionPeptides[211At] sodium astatideRadiation protectionTargeted alpha therapyThyroid cancer

Identifiers

PMID33978932
PMCPMC8197710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.